
HEXO Corp. HEXO
Annual report 2022
added 12-23-2023
HEXO Corp. DIO Ratio 2011-2026 | HEXO
Annual DIO Ratio HEXO Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 703 | 193 | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 703 | 193 | 448 |
DIO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aerie Pharmaceuticals
AERI
|
459 | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
167 | $ 1.11 | 4.25 % | $ 119 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
133 | - | 7.5 % | $ 6.35 M | ||
|
Catalent
CTLT
|
71.9 | - | - | $ 11.5 B | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
48.9 | - | 0.86 % | $ 117 M | ||
|
DURECT Corporation
DRRX
|
460 | - | - | $ 50.1 M | ||
|
Endo International plc
ENDP
|
100 | - | - | $ 28.9 M | ||
|
Agile Therapeutics
AGRX
|
82.7 | - | 10.11 % | $ 58.2 M | ||
|
Evoke Pharma
EVOK
|
995 | - | - | $ 36.6 M | ||
|
Alimera Sciences
ALIM
|
58.7 | - | - | $ 142 M | ||
|
Evolus
EOLS
|
71.3 | $ 5.57 | 34.75 % | $ 359 M | ||
|
Cronos Group
CRON
|
221 | $ 2.65 | 1.92 % | $ 1.38 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
366 | - | - | $ 2.06 B | ||
|
Harrow Health
HROW
|
65.1 | $ 40.0 | 3.61 % | $ 1.47 B | ||
|
Jupiter Wellness
JUPW
|
59.7 | - | - | $ 33.6 M | ||
|
China Pharma Holdings
CPHI
|
168 | $ 0.59 | 7.93 % | $ 10.3 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
239 | $ 3.8 | -17.03 % | $ 53.4 M | ||
|
Aurora Cannabis
ACB
|
1.35 K | $ 3.69 | 5.89 % | $ 86.3 M | ||
|
Athenex
ATNX
|
158 | - | -23.39 % | $ 1.76 M | ||
|
Organogenesis Holdings
ORGO
|
85.9 | $ 2.93 | 1.92 % | $ 386 M | ||
|
Emergent BioSolutions
EBS
|
176 | $ 8.95 | 0.34 % | $ 458 M | ||
|
ProPhase Labs
PRPH
|
30.1 | - | - | $ 5.07 M | ||
|
Assertio Holdings
ASRT
|
347 | $ 12.19 | 2.48 % | $ 866 M | ||
|
Radius Health
RDUS
|
204 | - | - | $ 1.42 B | ||
|
Rockwell Medical
RMTI
|
28.5 | $ 0.91 | 0.93 % | $ 21.2 M | ||
|
Bausch Health Companies
BHC
|
172 | $ 5.7 | -0.61 % | $ 2.08 B | ||
|
Lannett Company
LCI
|
127 | - | 1.15 % | $ 7.11 M | ||
|
Eagle Pharmaceuticals
EGRX
|
149 | - | -39.89 % | $ 27.7 M | ||
|
OrganiGram Holdings
OGI
|
2.83 K | $ 1.42 | 3.28 % | $ 402 M | ||
|
Perrigo Company plc
PRGO
|
148 | $ 11.66 | 2.42 % | $ 1.61 B | ||
|
TherapeuticsMD
TXMD
|
1.04 K | $ 2.25 | 1.35 % | $ 23.5 M | ||
|
Pacira BioSciences
PCRX
|
246 | $ 22.97 | 3.94 % | $ 1.06 B | ||
|
Veru
VERU
|
179 | $ 2.54 | 0.8 % | $ 343 M | ||
|
PetIQ
PETQ
|
64.9 | - | 1.64 % | $ 400 M | ||
|
OptiNose
OPTN
|
370 | - | - | $ 1.08 B | ||
|
Viatris
VTRS
|
140 | $ 14.88 | -0.1 % | $ 17.9 B | ||
|
PLx Pharma
PLXP
|
97.2 | - | -27.8 % | $ 2.56 M | ||
|
Recro Pharma
REPH
|
49.1 | - | -4.76 % | $ 65.3 M | ||
|
cbdMD
YCBD
|
165 | $ 0.74 | -4.01 % | $ 3.19 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
117 | $ 2.74 | -0.36 % | $ 3.4 M | ||
|
Tilray
TLRY
|
170 | $ 7.42 | 0.82 % | $ 4.59 B |